Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher
Go back to Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 66.81 -5.05 (7.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $71.86 | 52 Week High | $8.22 | |||
| Open | $72.16 | 52 Week Low | $3.07 | |||
| Day High | $72.49 | P/E | N/A | |||
| Day Low | $66.62 | EPS | $-1.30 | |||
| Volume | 809,569 | |||||
